Takaki Kagaya

Functional disorders of the sympathetic nervous system in mice lacking the α _1B subunit (Ca _v 2.2) of N-type calcium channels

Mitsuhiro Ino, Takashi Yoshinaga, Minoru Wakamori et al. · Proceedings of the National Academy of Sciences · 2001 · 141 citations · Full text

N-type Voltage-dependent Ca, Synaptic Transmission, Neurotransmitter +19

Dopamine D3 agonists disrupt social behavior in rats

Takaki Kagaya, Masahiro Yonaga, Yoshiaki Furuya et al. · Brain Research · 1996 · 31 citations

Behavioral Sciences, Behavioral Neuroscience, Social Behavior +5

Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice

Yoshiaki Furuya, Takaki Kagaya, Hiroo Ogura et al. · European Journal of Pharmacology · 1999 · 26 citations

Startle Amplitude, Dopamine Receptor-independent Manner, Functional Selectivity +10

Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats

Yoshiaki Furuya, Takaki Kagaya, Yukio Nishizawa et al. · Brain Research · 1998 · 15 citations

Molecular Pharmacology, Differential Effects, Pharmacological Study +9

A novel truncated glucagon-like peptide 2 (GLP-2) as a tool for analyzing GLP-2 receptor agonists

Kazuto Yamazaki, Takaki Kagaya, Misako Watanabe et al. · Biomedical Research · 2013 · 11 citations · Full text

Glp-2 Receptor Agonists, Signal Transduction, Glucagon-like Peptide 2 +13